Ramin FarhoodDr. RAMIN FARHOOD, senior VP at SSI Strategy, has over twenty-five years in patient-centric medical strategy. Previously at Novartis, he launched the world’s first gene therapy for spinal muscular atrophy. Farhood cofounded the Medical AffairsProfessional Society (MAPS) and the Immunoglobulin National Society (IgNS) and cohosts The Emerging Biotech Leader podcast. Read More Read Less